Guard Therapeutics International AB (publ) operates within the Commercial nonphysical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Guard Therapeutics International AB (publ) with three other
miscellaneous service companies in Europe:
Read-Gene SA
of POLAND
(2013
sales of 268,384.25 Polish New Zlotys [US$71,360.69 ]
),
General Technologies AG
of GERMANY
(82,294.51 Euros [US$97,505.00 ]
of which 100%
was Investment Income), and
European Institute of Science AB
(735,712.00 Swedish Kronor [US$83,834.38 ]
of which 100%
was Bio Medical Research).
Sales Analysis.